Intrinsic Value of S&P & Nasdaq Contact Us

SeaSpine Holdings Corporation SPNE NASDAQ

NASDAQ Global Select • Healthcare • Medical - Devices • US • USD

SharesGrow Score
41/100
1/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$9.38
-1.7%
SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

SeaSpine Holdings Corporation (SPNE) .

Criteria proven by this page:

  • VALUE (35/100, Fail) — the composite valuation score falls below the 60/100 threshold required to pass.
  • Analyst consensus target $9.38 (-1.7% downside) — slight downside risk — the market may be ahead of analyst expectations.

Overall SharesGrow Score: 41/100 with 1/7 criteria passed.

SharesGrow 7-Criteria Score
41/100
SG Score
View full scorecard →
VALUE
35/100
Price-to-Earnings & upside
Proven by this page
FUTURE
74/100
Analyst consensus
→ Forecast
PAST
0/100
→ Income
~
HEALTH
67/100
Debt-to-Equity & liquidity
→ Health
~
MOAT
54/100
→ Income
~
GROWTH
48/100
→ Income
INCOME
10/100
→ Income

Valuation Snapshot — SPNE

Valuation Multiples
P/E (TTM)0.0
Forward P/EN/A
PEG RatioN/A
Forward PEGN/A
P/B Ratio0.00
P/S Ratio1.67
EV/EBITDA0.0
Per Share Data
EPS (TTM)$-1.62
Book Value / Share$0.00
Revenue / Share$5.70
FCF / Share$0.00
Yields & Fair Value
Earnings YieldN/A
Dividend Yield0.00%
Analyst Target$9.38 (-1.7%)

EPS: Actual vs Estimates

P/E Ratio & Earnings Yield

Earnings Per Share (EPS) History

Year EPS (Diluted) Revenue Net Income Net Margin
2012 $-2.78 $147.51M $-30.42M -20.6%
2013 $-2.35 $146.59M $-25.75M -17.6%
2014 $-2.24 $138.7M $-24.55M -17.7%
2015 $-4.99 $133.18M $-55.53M -41.7%
2016 $-3.85 $128.86M $-43.21M -33.5%
2017 $-2.58 $131.81M $-32.12M -24.4%
2018 $-2.18 $143.44M $-33.52M -23.4%
2019 $-2.07 $159.08M $-39.28M -24.7%
2020 $-1.59 $154.35M $-43.18M -28%
2021 $-1.62 $191.45M $-54.35M -28.4%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message